Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II, Multi-center, Non-inferiority Clinical Trial for Efficacy and Safety of Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

NCT01344681 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01344681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01344681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II, Multi-center, Non-inferiority Clinical Trial for Efficacy and Safety of Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
March 31, 2014
Enrollment
153 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

febrile neutropenia, hematological diseases